Skip to main content
TipRanks
Go Ultimate75% OFF

Basilea Pharmaceutica (BPMUF) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

BPMUF Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Basilea Pharmaceutica in the past 3 months

BPMUF Stock 12 Month Forecast

$133.26▲(58.65% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Basilea Pharmaceutica in the last 3 months. The average price target is $133.26 with a high forecast of $133.26 and a low forecast of $133.26. The average price target represents a 58.65% change from the last price of $84.00.
Highest Price Target$133.26Average Price Target$133.26Lowest Price Target$133.26

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for BPMUF
Price TargetArticle
H.C. Wainwright$127.21→$133.26buy58.65%UpsideReiterated09/11/26
Kepler Capital $83.59→$84.80buy0.96%UpsideReiterated04/13/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Basilea Pharmaceutica

3 Months
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate5/8 ratings generated profit
63%
Average Return
+3.62%

Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +3.62% per trade.

1 Year
Christophe dombu
Christophe dombuKepler Capital
Success Rate15/16 ratings generated profit
94%
Average Return
+24.41%

Copying Christophe dombu's trades and holding each position for 1 Year would result in 93.75% of your transactions generating a profit, with an average return of +24.41% per trade.

2 Years
Christophe dombu
Christophe dombuKepler Capital
Success Rate16/16 ratings generated profit
100%
Average Return
+45.16%

Copying Christophe dombu's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +45.16% per trade.

BPMUF Analyst Recommendation Trends

01234Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for BPMUF
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00111
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00111

In the current month, BPMUF has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BPMUF average Analyst price target in the past 3 months is 133.26.

BPMUF Financial Forecast

$0$1.75$3.5$5.25$7Q2 2025Q2 2026Q4 2026
High$6.26
Consensus$5.13
Low$4.00

BPMUF Earnings Forecast

Next quarter’s earnings estimate for BPMUF is $5.13 with a range of $4.00 to $6.26. The previous quarter’s EPS was $2.60. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

$126.8M$153.7M$180.5M$207.4M$234.2MQ2 2025Q2 2026Q4 2026
High$234M
Consensus$201M
Low$181M

BPMUF Sales Forecast

Next quarter’s sales forecast for BPMUF is $201.12M with a range of $180.91M to $234.22M. The previous quarter’s sales results were $145.16M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

BPMUF Stock Forecast FAQ

What is BPMUF’s average 12-month price target, according to analysts?
Based on analyst ratings, Basilea Pharmaceutica’s 12-month average price target is $133.26.
What is BPMUF’s upside potential, based on the analysts’ average price target?
Basilea Pharmaceutica has 58.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BPMUF a Buy, Sell or Hold?
Basilea Pharmaceutica has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Basilea Pharmaceutica’s price target?
The average price target for Basilea Pharmaceutica is $133.26. This is based on 1 12-month price targets, issued in the past 3 months. The highest analyst price target is $133.26, the lowest forecast is $133.26. The average price target represents a 58.65% increase from the current price of $84.
What do analysts say about Basilea Pharmaceutica?
Basilea Pharmaceutica’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of BPMUF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.